Medicus Pharma Ltd.
MDCX
$0.26
$0.013.46%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -28.48% | 50.58% | 12.60% | -238.98% | -21.04% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -100.00% | -- |
| Total Other Non-Cash Items | 63.06% | -70.42% | -75.34% | 4,443.05% | 151.47% |
| Change in Net Operating Assets | 363.22% | -269.07% | 146.88% | -626.18% | -75.24% |
| Cash from Operations | 22.14% | -35.72% | 2.20% | -23.57% | -38.77% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 100.00% | -- | -- |
| Cash from Investing | -- | -- | 100.00% | -- | -- |
| Total Debt Issued | -- | -- | -100.00% | 63.70% | -- |
| Total Debt Repaid | 26.29% | -81.64% | 68.90% | -- | -- |
| Issuance of Common Stock | -35.14% | 18.10% | -5.94% | 29.04% | 84.54% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 81.26% | -12.61% | -1,209.60% |
| Cash from Financing | 274.05% | 2.58% | -35.85% | -7.03% | 196.77% |
| Foreign Exchange rate Adjustments | 243.31% | -16,158.33% | 29.41% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 904.66% | -5,528.31% | 104.28% | -117.72% | 3,226.50% |